WHO CBD Report; the World Health Organization
Recently, the World Health Organization (WHO) deemed Cannabidiol (CBD) as a safe, non-toxic, and non-addictive substance. This was according to the WHO CBD report, and more of its findings will be discussed below. Besides CBD being a non-psychoactive cannabinoid, it can also deliver a plethora of potential medicinal and therapeutic benefits. CBD can even help improve individuals’ quality of life and well-being.
Although Cannabidiol is classified as an illegal substance in many countries, other countries are going in the opposite direction. For example, certain countries are studying CBD more than ever before. In addition, they are allowing people to legally sell and consume the substance. Keep reading to find out various noteworthy takeaways stated in the WHO CBD report.
WHO CBD Report Findings—Non-toxic, Non-addictive, and Safe
Thus far, the public is aware of the several potential medicinal, therapeutic, and nutritional benefits of CBD. However, CBD has other potential benefits too, which are outlined in the WHO CBD report. The report went on to express information about CBD’s abuse risks:
“CBD appears to have little effect on conditioned place preference or intracranial self-stimulation. In an animal drug discrimination model, CBD failed to substitute for THC. In humans, CBD exhibits no effects indicative of any abuse or dependence potential.”
Then, the report stated the following about CBD’s non-toxic make-up, “CBD has been found to have relatively low toxicity, although not all potential effects have been explored.” From here, the safety of CBD was revealed. Specifically, the report released this statement about the safety of Cannabidiol, “CBD is generally well tolerated with a good safety profile.” Thus, not only is CBD non-toxic, non-psychoactive, and non-addictive, it is also safe to consume. What more could you want from a natural medicine that is derived from plants?
In addition, the WHO CBD report mentioned that Cannabidiol does not deliver the same effects as THC does. Fortunately for consumers, so far, the cannabinoid has not shown “THC-like discriminative stimulus effects”. Furthermore, it was discovered from a human study that CBD did not succeed at producing abuse potential effects. Then, the report described CBD’s lack of dependency risks by stating the following, “No studies of the physical dependence potential of CBD in animals were identified.” Regarding humans, there have been no reports on the potential physical dependence effects from CBD usage.
Limited Research Findings on CBD
Unfortunately, over the years, a limited amount of research has been conducted on CBD in the form of human studies. However, one findings result conclude with human studies. The finding is the indication that CBD is not related to abuse potential. Additionally, the WHO CBD report went on to state the following about current health problems associated with the cannabinoid: “At present, there are no case reports of abuse or dependence relating to the use of pure CBD.”
Similarly, the report described the lack of public health issues caused by CBD by mentioning this finding, “At present, no public health problems (e.g. driving under the influence of drugs cases, comorbidities) have been associated with the use of pure CBD.”
On a positive note, according to existing preliminary evidence and limited clinical trials, CBD can help treat various medical conditions and diseases. The WHO CBD report went further by mentioning CBD’s ability to treat different medical conditions like epilepsy, anxiety, Multiple Sclerosis, cancer, Rheumatoid Arthritis, IBD, depression, and more.
Classifications of CBD
Although CBD is illegal in many countries, it is becoming more prevalent all over the world. Due to the cannabinoid’s powerful effects and medicinal capabilities, certain countries are shifting their stance on CBD. In particular, the U.S. FDA reduced the country’s regulatory requirements in 2015 to permit researchers to conduct CBD trials.
From here, the WHO CBD report included the classifications of CBD in multiple countries including the following: Canada, Australia, New Zealand, the UK, and Switzerland.
Now that you are aware of some noteworthy findings from the recent WHO CBD report, would you give CBD a try? If so, which CBD products would you try first?